Insider · CIK 0002103998
Jonathan C Meltzer
Files at LH (LABCORP HOLDINGS INC.). First filing Feb 10, 2026, latest Mar 30, 2026.
In brief
Jonathan C Meltzer files SEC Form 4 as COO at LH (LABCORP HOLDINGS INC.). Since Feb 10, 2026, Jonathan C Meltzer has reported 0 open-market buys worth $0 and 4 open-market sells worth $299k, the latest filed on Mar 30, 2026.
A track record needs three past buys with six months of prices behind them; Jonathan C Meltzer has 0, so none is measured yet.
The newest scored trade: sold $224k of LH on Mar 27, 2026, filed Mar 30, 2026, scored 20 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $299k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LH: LABCORP HOLDINGS INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | LABCORP HOLDINGS INC. | $224k 839 shares | -19% | +26% from low-9% from high | |
| 0Weak | LABCORP HOLDINGS INC. | $25k 87 shares | -3% | +32% from low-4% from high | |
| 15Weak | LABCORP HOLDINGS INC. | $25k 91 shares | -3% | +35% from low-2% from high | |
| 0Weak | LABCORP HOLDINGS INC. | $24k 88 shares | -3% | +30% from low-6% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 27, 2026 | LH LABCORP HOLDINGS INC. | 839 0.00% of outstanding | $224k | Mar 27, 2026 | $75k |
| Feb 12, 2026 | LH LABCORP HOLDINGS INC. | 87 0.00% of outstanding | $25k | Feb 12, 2026 | $49k |
| Feb 10, 2026 | LH LABCORP HOLDINGS INC. | 91 0.00% of outstanding | $25k | Feb 10, 2026 | $24k |
| Feb 9, 2026 | LH LABCORP HOLDINGS INC. | 88 0.00% of outstanding | $24k | Feb 9, 2026 | none |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | LH LABCORP HOLDINGS INC. | AGrant or award Restricted Stock Unitderivative | +900 | $0.00 | $0 | 3,594 | 40 d ago |
| Mar 26, 2026 | LH LABCORP HOLDINGS INC. | AGrant or award Common Stock10b5-1 | +2,388 | $0.00 | $0 | 5,170 | Mar 30, 2026 |
| Mar 26, 2026 | LH LABCORP HOLDINGS INC. | FTax withholding Common Stock10b5-1 | -711 | $268.38 | $191k | 4,459 | Mar 30, 2026 |
| Mar 27, 2026 | LH LABCORP HOLDINGS INC. | SOpen-market sale Common Stock10b5-1 | -839 | $267.05 | $224k | 3,620 | Mar 30, 2026 |
| Feb 11, 2026 | LH LABCORP HOLDINGS INC. | MOption exercise Common Stock10b5-1 | +243 | - | - | 2,939 | Feb 13, 2026 |
| Feb 11, 2026 | LH LABCORP HOLDINGS INC. | FTax withholding Common Stock10b5-1 | -70 | $289.89 | $20k | 2,869 | Feb 13, 2026 |
| Feb 12, 2026 | LH LABCORP HOLDINGS INC. | SOpen-market sale Common Stock10b5-1 | -87 | $290.42 | $25k | 2,782 | Feb 13, 2026 |
| Feb 11, 2026 | LH LABCORP HOLDINGS INC. | MOption exercise Restricted Stock Unitderivative10b5-1 | -243 | $0.00 | $0 | 2,694 | Feb 13, 2026 |
| Feb 10, 2026 | LH LABCORP HOLDINGS INC. | SOpen-market sale Common Stock10b5-1 | -91 | $276.79 | $25k | 2,696 | Feb 12, 2026 |
| Feb 10, 2026 | LH LABCORP HOLDINGS INC. | AGrant or award Non-qualified Stock Optionsderivative10b5-1 | +1,900 | $0.00 | $0 | 1,900 | Feb 12, 2026 |
| Feb 10, 2026 | LH LABCORP HOLDINGS INC. | AGrant or award Restricted Stock Unitderivative10b5-1 | +620 | $0.00 | $0 | 2,937 | Feb 12, 2026 |
| Feb 6, 2026 | LH LABCORP HOLDINGS INC. | MOption exercise Common Stock10b5-1 | +267 | - | - | 2,785 | Feb 10, 2026 |
| Feb 6, 2026 | LH LABCORP HOLDINGS INC. | FTax withholding Common Stock10b5-1 | -91 | $277.20 | $25k | 2,694 | Feb 10, 2026 |
| Feb 7, 2026 | LH LABCORP HOLDINGS INC. | MOption exercise Common Stock10b5-1 | +263 | - | - | 2,957 | Feb 10, 2026 |
| Feb 9, 2026 | LH LABCORP HOLDINGS INC. | SOpen-market sale Common Stock10b5-1 | -88 | $275.53 | $24k | 2,869 | Feb 10, 2026 |
| Feb 9, 2026 | LH LABCORP HOLDINGS INC. | FTax withholding Common Stock10b5-1 | -82 | $274.01 | $22k | 2,787 | Feb 10, 2026 |
| Feb 6, 2026 | LH LABCORP HOLDINGS INC. | MOption exercise Restricted Stock Unitderivative10b5-1 | -267 | $0.00 | $0 | 2,580 | Feb 10, 2026 |
| Feb 7, 2026 | LH LABCORP HOLDINGS INC. | MOption exercise Restricted Stock Unitderivative10b5-1 | -263 | $0.00 | $0 | 2,317 | Feb 10, 2026 |
Questions about Jonathan C Meltzer
Answered from the filings on this page, as of the latest one.
Is Jonathan C Meltzer buying or selling?
In the last 12 months Jonathan C Meltzer reported 0 open-market buys worth $0 and 4 open-market sells worth $299k on SEC Form 4; the latest was sold $224k of LH on Mar 27, 2026. Grants, option exercises and tax withholding are not counted.
How did Jonathan C Meltzer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan C Meltzer has 0.
Where does Jonathan C Meltzer file Form 4?
Jonathan C Meltzer has filed Form 4 at LH (LABCORP HOLDINGS INC.) as EVP, Operations. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.